Full-Dose Anticoagulation Benefits Critically Ill With COVID-19
Full-dose anticoagulation reduces thrombotic complications in critically ill patients with COVID-19, according to a study published in Circulation. David A. Morrow, MD, and colleagues examined the safety and efficacy of...
Read More